|
|
Volumn 337, Issue 6098, 2012, Pages 1034-1037
|
|
The new view of complement
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
COMPLEMENT;
COMPLEMENT COMPONENT C1S INHIBITOR;
COMPLEMENT COMPONENT C3;
COMPLEMENT COMPONENT C3A;
COMPLEMENT COMPONENT C3B;
COMPLEMENT COMPONENT C5;
COMPLEMENT COMPONENT C5A;
ECULIZUMAB;
ENZYME ACTIVITY;
GENE EXPRESSION;
GENOMICS;
IMMUNE SYSTEM;
INHIBITOR;
PATHOGEN;
PROTEIN;
COMPLEMENT SYSTEM;
DRUG COST;
DRUG TARGETING;
GENETIC ENGINEERING;
HUMAN;
IMMUNOSURVEILLANCE;
INFLAMMATION;
KNEE OSTEOARTHRITIS;
NONHUMAN;
PHAGOCYTOSIS;
PRIORITY JOURNAL;
PROTEIN TARGETING;
RETINA MACULA AGE RELATED DEGENERATION;
SEPSIS;
SHORT SURVEY;
ANIMAL;
DRUG DESIGN;
GENETICS;
IMMUNOLOGY;
LIVER REGENERATION;
MOUSE;
MOUSE MUTANT;
NOTE;
OSTEOARTHRITIS;
PATHOLOGY;
ANIMALS;
COMPLEMENT SYSTEM PROTEINS;
DRUG DESIGN;
HUMANS;
LIVER REGENERATION;
MICE;
MICE, MUTANT STRAINS;
OSTEOARTHRITIS;
|
|
EID: 84865549729
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.337.6098.1034 Document Type: Short Survey |
|
Times cited : (27)
|
|
References (0)
|
